Thad Allen Huston - 18 Feb 2026 Form 3 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Role
Chief Financial Officer
Signature
/s/ Andrew Cronauer, Attorney-in-Fact
Issuer symbol
ARTV
Transactions as of
18 Feb 2026
Net transactions value
$0
Form type
3
Filing time
24 Feb 2026, 17:15:51 UTC
Next filing
10 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Huston Thad Allen Chief Financial Officer C/O ARTIVA BIOTHERAPEUTICS, INC., 5505 MOREHOUSE DRIVE, SUITE 100, SAN DIEGO /s/ Andrew Cronauer, Attorney-in-Fact 24 Feb 2026 0001706052

No securities are beneficially owned.